Europe Insulin Patch Pump Market 2023-2030

Europe Insulin Patch Pump Market 2023-2030

Market Outlook

As per the analysis by Triton Market Research, Europe’s insulin patch pump market will develop at a CAGR of 10.00% during the forecasted period from 2023 to 2030. Poland, Spain, the United Kingdom, Germany, France, Italy, and Rest of Europe are scrutinized in this region’s market.

According to the World Bank’s estimates, in 2021, the diabetes prevalence in Poland was 6.8% for people in the age group of 20 to 79 years. Additionally, as per the IDF’s data, diabetes-related expenditure per person in the country was $994.3 that year.

The increasing occurrence of diabetes and the presence of supportive healthcare programs in the country are expected to drive demand for insulin patch pumps in the country. This, in turn, will foster the market’s growth over the forecast period.

The rising prevalence of diabetes and an increasing aging population are likely to drive market expansion in Italy over the forecast period. The nation has a well-developed diabetes care system, with a number of diabetic centers.

The National Diabetes Plan provides recommendations for improving the quality of diabetes care with a patient-centric approach. A rising number of government programs have increased awareness about diabetes self-management, which is expected to foster the studied market’s growth in the country over the projected period.

The countries assessed in Rest of Europe include Denmark, Belgium, Norway, and Switzerland, among others. The growing advancements in medical device technology and the rising prevalence rate of diabetes are expected to drive the studied market’s growth in the region over the coming years.

Competitive Outlook

The notable players thriving in the insulin patch pump market include Tandem Diabetes Care Inc, Terumo Corporation, Insulet Corporation, F Hoffmann La Roche AG, and Debiotech SA.